section name header

Pronunciation

dye-klox-a-SILL-in

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: penicillinase resistant penicillins

Indications

REMS


Action

  • Bind to bacterial cell wall, leading to cell death. Not inactivated by penicillinase enzymes.
Therapeutic effects:
  • Bactericidal action.

Spectrum:

Pharmacokinetics

Absorption: Rapidly but incompletely (35–76%) absorbed from the GI tract.

Distribution: Widely distributed; penetration into CSF is minimal but sufficient in the presence of inflamed meninges; cross the placenta and enter breast milk.

Protein Binding: 96–98%.

Metabolism/Excretion: Some metabolism by the liver (6–10%) and some renal excretion of unchanged drug (60%); small amounts eliminated in the feces via the bile.

Half-Life: 0.5–1 hr ( in severe hepatic and renal dysfunction).

Time/Action Profile

ROUTEONSETPEAKDURATION
Dicloxacillin PO30 min30–120 min6 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes